BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32752034)

  • 1. Drug Use among Nursing Home Residents in Denmark for Drugs Having Pharmacogenomics Based (PGx) Dosing Guidelines: Potential for Preemptive PGx Testing.
    Vermehren C; Søgaard Nielsen R; Jørgensen S; Drastrup AM; Westergaard N
    J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32752034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug-Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients.
    Westergaard N; Søgaard Nielsen R; Jørgensen S; Vermehren C
    J Pers Med; 2020 Jan; 10(1):. PubMed ID: 31963319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Multidrug Use in the General Population and among Persons with Diabetes in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines.
    Westergaard N; Tarnow L; Vermehren C
    Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization.
    Westergaard N; Baltzer Houlind M; Christrup LL; Juul-Larsen HG; Strandhave C; Olesen AE
    Basic Clin Pharmacol Toxicol; 2024 Apr; 134(4):531-542. PubMed ID: 38308569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy.
    Westergaard N; Tarnow L; Vermehren C
    Metabolites; 2021 Feb; 11(2):. PubMed ID: 33578832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?
    Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC
    J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
    Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
    Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database.
    Wittwer NL; Meier CR; Huber CA; Meyer Zu Schwabedissen HE; Allemann S; Schneider C
    Pharmgenomics Pers Med; 2022; 15():967-976. PubMed ID: 36447837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
    Alshabeeb MA; Alyabsi M; Paras B
    Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal pharmacogenomics: A promising addition to complex neonatal care.
    Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
    Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Pharmacogenetic Drugs by the Dutch Population.
    Alshabeeb MA; Deneer VHM; Khan A; Asselbergs FW
    Front Genet; 2019; 10():567. PubMed ID: 31312209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients.
    Niedrig DF; Rahmany A; Heib K; Hatz KD; Ludin K; Burden AM; Béchir M; Serra A; Russmann S
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer.
    Bernard PS; Wooderchak-Donahue W; Wei M; Bray SM; Wood KC; Parikh B; McMillin GA
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting.
    Mostafa S; Polasek TM; Sheffield LJ; Huppert D; Kirkpatrick CMJ
    Front Psychiatry; 2021; 12():724170. PubMed ID: 34489765
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada.
    Fan M; Yarema MC; Box A; Hume S; Aitchison KJ; Bousman CA
    Pharmacogenet Genomics; 2021 Feb; 31(2):29-39. PubMed ID: 32826605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.
    Dong OM; Li A; Suzuki O; Oni-Orisan A; Gonzalez R; Stouffer GA; Lee CR; Wiltshire T
    Pharmacogenomics; 2018 Jun; 19(9):771-782. PubMed ID: 29793377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
    Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
    Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.